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Abstract
Cancer is a disease of uncontrolled cell growth and abnormal cell proliferation.
There are a myriad of genetic modifications that disrupt proper cell functioning and can
lead to cancer, and recent studies have suggested that improper chromatin remodeling
may be yet another mechanism that leads to uncontrolled cell proliferation.
Chromo domain helicase DNA binding proteins (CHD) are a family of proteins that have
been associated with chromatin regulation and as a result, genome transcription
regulation. Studies on the CHD family could have implications in cancer research
because of the proteins' role in chromatin remodeling, gene expression and possibly
chromosomal stability.
Research in our laboratory focuses on the Chromodomain helicase binding 2
protein (CHD2). Previously, the lab developed a CHD2 deficient mouse model which is
characterized by a high susceptibility for lymphomas. The goal of this research project
was to analyze the molecular mechanisms of Chd2 deficiency induced lymphomas and
determine if the Chd2 protein is a substrate for A TM kinase, a well known DNA damage
signaling kinase. To this end, an HA-tagged version of Chd2 was transfected into human
cancer cell lines and exposed to DNA-damaging stimulus. Analysis of the Chd2 peptides
for ATM specific phosphorylation indicated that the results so far were inconclusive.
Additional experiments to unequivocally determine the phosphorylation of Chd2 by
ATM are currently being planned and discussed.
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Introduction

Cancer is a disease of uninhibited cell growth and atypical cell proliferation. The
stability of the genome, the fidelity of its replication, and the efficiency of DNA
replication are crucial to normal cell growth and development. The genetic material is
manipulated several times throughout the cell's lifecycle, greatly increasing the chances
of incorporating mistakes and developing DNA damage. The enormously lengthy
genome must be packaged in order to fit within the nucleus of the cell. In the initial step
of the DNA condensing process, the naked double-stranded DNA is wound around an
octamer of basic histone proteins, producing a nucleosome. The nucleosome consists of
a core of five types of histones, HI, H2A, H2B, H3, and H4, and DNA wrapped about 1.8
times around the core [1]. Each nucleosome occurs at regular intervals along a DNA
strand, resulting in a "beads on a string" formation. Further winding and looping results
in a chromatin fiber and higher level structures, ultimately forming the characteristically
compact chromosome form which can easily fit within the confines of the cell's nucleus.
The later steps are dependent on a correctly executed nucleosome configuration;
however, by intentionally changing the charge on histones, the cell can render genes
active, inactive, or responsive to developmental and external signals [2].
The reverse of this compaction process is equally important. Transcription
repression is caused by packaging promoters within nucleosomes, which prevents
initiation. It is therefore, very important to unpack DNA to give RNA polymerases and
other related proteins access to the genetic material. This allows for genomic
transcription and elongation, and further downstream, protein formation. In order to
counteract the condensing activity of nucleosomes and free the promoter regions, cells
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have chromatin-remodeling complexes which can disrupt DNA-histone interactions by
clearing a portion ofnucleosome-free DNA in an ATP-dependent manner. Initiation of
transcription by chromatin remodeling can occur through a variety of mechanisms
including destabilizing the nucleosome itself (SWIISNF -related complexes), transferring
histones octamers to a separate DNA molecule (RSC, a member of the SWI/SNF family),
and "sliding" histones to different areas along the same strand of DNA (lSWI complexes)
[3]. Elongation, in contrast, can occur regardless ofnucleosomes. RNA polymerase
(pol) II can continue to transcribe while the cell maintains the nucleosome structure by
recruiting a number of elongation, chromatin-related, and chromatin-remodeling factors
to the site of elongation [3, 4].

In addition to its role in transcription and elongation, chromatin-remodeling plays
a role in other chromatin-based processes including, recombination, regulation of gene
expression, and double-strand DNA (dsDNA) repair response. Chromatin remodeling
complexes such as the well-studied SWI-SNF family assist in dsDNA break repair more
specifically through the homologous recombination pathway. The ATP-dependent
complexes, SWI-SNF and RSC, hydrolyze histones or rearrange nucleosomes, allowing
greater accessibility of regulatory proteins to the undamaged sister chromosome's DNA
[5]. By exposing the homologous donor sequence, the chromatin-remodeling complexes
allow homology-searching complexes to work. Defects in chromatin-remodeling
complexes show poor cellular response to DNA double strand breaks, resulting in an
accumulation of genomic alterations and the potential for cancer development. The well
characterized SWIISNF family has been long defined as a chromatin remodeler. The
lesser known, poorly-studied chromo domain helicase DNA-binding (Chd) family has just
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recently demonstrated its importance in transcription regulation and developmental
processes [11].
The Chd family
The Chromodomain helicase DNA binding (Chd) family of genes encode a group
of ATP-dependent chromatin remodeling proteins. They are part of the SNF2
superfamily of proteins. All members of the Chd family are distinguished by two
sequence motifs: tandem chromo domains (Chromatin organization modifier) and SNF2
like ATPase domains. Chd proteins are activated by single-stranded, double-stranded, or
nucleosomal DNA and exert their effects on transcriptional activation by aiding in
chromatin remodeling. Because the Chd proteins render chromatin into transcriptionally
inactive heterochromatic form, it is suggested that Chd could playa role in gene
expression as a negative regulator [7].
The chromodomain is a 50 amino acid region. The evolutionarily conserved
sequence is found to have a role in chromatin-structure remodeling in an ATP-dependent
manner and transcriptional regulation of genes. Chromodomains are characteristically
found in proteins that can interact with heterochromatin such as heterochromatin protein
1 (RPl) and polycomb (Pc) proteins [8]. Importantly, the chromodomain and helicase
domains have been found to be necessary for appropriate interaction with chromatin.
This association is mediated by the chromodomain, which binds the protein directly to
RNA, DNA, and methylated R3 histone [6]. Other functions of Chd family members
include association with transcriptional repression. In general, Chd family proteins playa
crucial role in chromatin-related processes, particularly gene expression.
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The Chd family is further broken down into three subfamilies: The Chdl-Chd2
family, the Chd3-Chd4 family, and the Chd5-Chd9 family. Each subfamily has its own
identifying structures, domains, and functions. Briefly, the Chdl-Chd2 proteins contain a
229 amino acid region near the C-terminus used as a DNA-binding domain which
preferentially binds to AT-rich DNA sequences. The Chd3-Chd4 family most notably
lacks the DNA-binding domain. Instead, the proteins have two N-terminal plan homeo
domains (PHD) which resembles Zn-finger domains. The subfamily consisting of Chd5
Chd9 has extra domains, including paired Brahma and Kismet (BRK) domains, switch
defective protein 3, adaptor 2, nuclear receptor co-repressor transcription factor IIIB
(SANT-like) domain, CR domains, and a DNA-binding domain. As with the Chdl-Chd2
family, Chd5-Chd9's DNA-binding domain shows a preference for AT-rich DNA
portions [6].
Of the Chd family of proteins, Chdl is one of the better characterized. Both
mouse Chdl (MmCHDI) and human Chdl (HsCHD1) have a pair of chromodomains, a
single helicase/A TPase domain, and a DNA-binding domain. Chd l' s biggest role seems
to be in interacting between transcribed genes and transcription elongation factors, as
evidenced by its physical interactions with RNA elongation complexes PAF, FACT, and
Spt4/5 [9]. In humans, it has been shown that PAF, FACT, and associated ubiquitylation
factors move onto the transcribed regions. Subsequent monouibiquitylation of H2B leads
to trimethylation ofH3K4 which is theorized to recruit Chdl [9]. Recent data has shown
that Chdl may playa crucial role in transcription termination with RNA pol II because of
its localization to 3'-untranslated regions of genes [10]. Finally, Chdl is speculated to
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have a potential role in replication because of its association with Spt16 and Pob3, which
may be involved in replication [10].
The other member of the first subfamily, Chd2, is closely related to Chdl. Chd1
and Chd2 share a high homology between chromo domain motifs (77. 9% similarity) and
helicase/ATPase domains (92.3% similarity); however, their greatest differences are in
the DNA-binding domain (75.1 % similarity) [10]. Chd2 has several distinctive structural
motifs: several bipartite nuclear localization signals (NLS-BP), a Myb-DNA binding
domain, a centrally located helicaselATPase domain, paired chromodomains near the N
terminus, and an A+T hook. The Myb-DNA binding domain is a DNA binding domain
(DBD) unique for its consensus sequence and the two-fold manner in which it binds
protein and DNA, through contact with either the sugar phosphate backbone or the base
itself [11]. This Myb-related DBD has been suggested to playa role in cell
differentiation and proliferation [12]. The helicase/ATPase domain putatively allows
efficient Chd functioning by altering DNA-protein interactions and unwinding DNA [7].
The A+T hook allows for preferential Chd binding to A-T rich sequences of DNA [7].
The chromo domain, chromatin organization modifier, is a 50 amino acid motif with roles
in chromatin remodeling and transcriptional gene regulation [6].
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Figure 1. Schematic diagram of the Chd2 protein structure representing various domains.
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Putative functions of Chd2 include a role in development and differentiation
through cell-cycle progression [13]. Data shows that Chd2 deficient heterozygous mouse
models survived past perinatal stages, but sustained multiple organ anomalies [13]. Chd2
deficient homozygous mouse models did not survive either because of embryonic
lethality or post-birth infanticide [13]. Research into Chd2 and its functions is still in its
infancy. Not much is known about the protein, but due to the Chd family's role in
chromatin regulation, it is suggested that Chd2 may have a role in cancer prevention
because of its role in chromosomal stability.
Ataxia telangiectasia mutated protein (A TM)
Ataxia telangiectasia mutated (ATM) is a protein kinase that is integral in several
double strand DNA (dsDNA) breaks. ATM coordinates a series of complicated, multi
passage system of pathways that react to dsDNA breaks. These pathways then
momentarily halt the cell cycle and organize to repair the DNA damage. Named for the
mutated gene in the human disorder ataxia telangiectasia (AT), ataxia telangiectasia
mutated (ATM) is part of a protein family that has kinase activity at serine/threonine
motifs [14]. ATM is a 3056 amino acid protein with sequential FAT domain, PI(3)K
domain, and FATC domain at the carboxy-terminus [15]. The FAT and FATC domain
functions have not yet been clearly elucidated. The PI(3)K domain is named for its
homology with phosphotidylinositol-3-0H-kinases' catalytic sequences and contains the
motifs for the catalytic site of the protein [16].
A TM and related protein ATR, when activated, have the potential to bring about
G 1 arrest, G2 arrest, cell repair, and/or activate stress response genes. Through
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phosphorylation of substrates such as Brca1, NBS1, p53, Chk1l2, and Mdm2, ATM can
help promote cell genome stability [16, 17].
ATM is primarily activated by double strand DNA breaks caused by IR. Because
of ATM's impressively quick response to DNA breaks, the mechanism for ATM
activation has been highly contended. It has yet to be determined whether A TM is
directly activated by DNA damage and physical contact with the break or indirectly
activated through chromatin alteration. Research has shown that A TM may
autophosphorylate a dimeric inactive form of itself. Constitutively, ATM is proposed to
exist in some form of multimer, held in check by the FAT domain. Post DNA damage,
ATM responds by phosphorylating the other units in the FAT domain, freeing all units
involved. The ATM protein can then become active as a monomer [16].
ATM plays an important role in genome protection and genomic stability. The
best-studied ATM activity is the response to double strand DNA breaks. The almost
immediate response is effective because of ATM' s activation strategies. A TM stimulates
its many substrates through several different mechanisms, ensuring activation of the
necessary downstream targets. This is demonstrated by p53, a defined tumor repressor
and ATM substrate. ATM can directly phosphorylate p53, phosphorylate CHK2, which
in tum phosphorylates p53, or phosphorylate MDM2, which leads to the degradation of
p53. These changes in p53 arbitrate the G 1-S stage of the cell cycle. ATM also adopts
an "all roads lead to Rome" strategy in which it works from different pathways to a
common end point. The S-G2 cell cycle checkpoint is controlled by A TM through
several different pathways; the BRCA 1, CHK2, and SMC 1 substrates all activate
separate paths that have the common end of halting the cell cycle at the S phase. Finally,
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ATM utilizes a "domino effect" which can activate substrates into kinases themselves.
The resulting kinases can phosphorylate downstream targets, increasing the efficiency
with which A TM responds to DNA damage [16].
Some notable ATM substrates and pathways include p53, CHK1/2, SMC1,
BRCA1, NBS 1, and MDM2. All pathways result in some form of cell cycle control at
various checkpoints. Cell cycle checkpoints are important in normal replication and cell
growth. In response to abnormal signals, checkpoints can temporarily halt the cell cycle
or signal cell death. There is redundancy within the pathway intermediates and
endpoints, demonstrating ATM's efficiency at responding to DNA strand breaks [17].
A TM also has other potential mechanisms by which it protects a celL A TM has been
suggested to participate in cell cycle checkpoint activation and may playa role in
preserving telomeres, the protective genome sequence at chromosome ends [16].
Because of ATM's integral role in genomic stability, there is strong link between ATM
mutations and cancer.
Rationale
ATM is known to phosphorylate serine/threonine (S/Q) motifs. Research has
shown that in order for phosphorylation to occur, hydrophobic amino acids must be
present at N-I and N-3 positions [11]. Analysis of the mouse Chd2 amino acid sequence
revealed ten S/Q motifs as potential ATM phosphorylation sites. Further analysis of the
S/Q motif sequences showed five out of the ten possible phosphorylation sites had a
hydrophobic amino acid at either the N-I or N-3 positions, and only one out often had
both. The central hypothesis of this project is that Chd2 is an A TM substrate and
functions at the chromatin level to affect DNA damage responses including DNA damage
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specific chromatin remodeling and repair. This is based on our previous work with the
Chd2 mouse model that are susceptible to lymphomas and the Chd2 mutant cells that
accumulate spontaneous DNA strand breaks.
1 mmrnkdksqe edsslhsnas srsaseevsg sdsgsqsese qgsepgsghg sesnsssess
61 esqseseses agsksqpvlp eakekpaskk eriadvkkmw eeypdvygvr rsnrsrqeps
121 rfnvkgeass gsesgspkrr gqrqlkkqek wkqdpsedeq eqgtsaesea eqkkgkarrp
181 vprrtvpkpq vkkqpkiqrg krkkqessdd dddddeapkr qtrrraaknv sykedddfet
241 dsddliemtg eggdeqqdns etiekvldsr Igkkgatgas ttvyaveang dpsddfdter
301 eegevqylik wkgwsyihst wesedslqqq kvkglkklen fkkkedevkq wlgkvspedv
361 eyfscqqela selnkqyqiv erviavktsk stlgqtdfpa hsrkpapsne peylckwmgl
421 pysecswede aligkkfqnc idsfhsrnns ktiptrecka Ikqrprfval kkqpaylgge
481 slelrdyqle glnwlahswc ks(nsvilade mglgktiqti sflsylfhqh qlygpflivv
541 plstltswqr efeiwapein vvvyigdims rntireyewi hsqtkrlkfn alittyeill
601 kdktvlgsin waflgvdeah rlknddslly ktlidfksnh rllitgtp)lq nslkelwsll
661 hfimpekfef wedfeedhgk grengyqslh kvlepfllrr vkkdvekslp akveqilrve
721 msalqkqyyk wiltrnykal akgtrgstsg flnivmelkk ccnhcylika pedseresgq
781 evlqslirss gklilldkll trlrergnrv lifsqmvrml dilaeyltik hypfqrldgs
841 ikgeirkqal dhfnadgsed fcfllstrag glginlasad tvvifdsdwn pqndlqaqar
901 ahrigqkkqv niyrlvtkgt veeeiierak kkmvldhlvi qrmdttgrtv lennsgrsns
961 npfnkeelta ilkfgaedlf keiegeesep qemdideilr laetrenevs tsatdellsq
1021 fkvanfatme deeeleerph kdwdeiipee qrkkveeeer qkeleeiyml prirsstkka
1081 qtndsdsdte skrqaqrssa sesetddsdd dkkpkrrgrp rsvrkdlveg ftdaeirrfi
1141 kaykkfglpl erleciarda elvdksvadl krlgelihns cvsamqeyee qlkestsegk
1201 gpgkrrgpti kisgvqvnvk siiqheeefe mlhksipvdp eekkkycitc rvkaahfdve
1261 wgveddsrlllgiyehgygn weliktdpel kltdkilpve tdkkpqgkql qtrvdyllkl
1321 Irkglekkgt vasgeeaklk krkprvkken kaprlkdehg lepasprhsd npseegevkd
1381 dgleksptkk kqkkkenken kekpvssrkd regdkerkks kdkkekvkgg dgkssskskr
1441 sqgpvhitag sepvpigede dddldqetfs ickermrpvk kalkqldkpd kglsvqeqle
1501 htrncllkig driaeclkay sdqehiklwr rnlwifvskf tefdarklhk Iykmahkkrs
1561 qeeeeqkkkd dslggkkpfr peasgssrds lisqshtshn Ihpqkphlpa shgpqmhghp
1621 rdnyshpnkr hfsnadrgdw qrerkfnygg gnsapwggdr hhqyeqhwyk dhhygdrrhm
1681 dahrsgsyrp nnmsrkrpye qynsdrdhrg hrdyydrhhh dskrrrsddf rpqnyhqqdf
1741 rrmsdhrptm gyhgqgpsdh yrsfhtdklg eykqpmpslh talsdprspp sqksphdsks
1801 pldhrspler sleqknnpdy nwnvrkt

Figure 2. The mouse Chd2 amino acid sequence. The ten SQ motifs are shown in bold.
The mouse Chd2 peptide sequence was obtained from the Ensemble database (version m36).
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Materials and Methods

Sequence analysis
Computational analysis of the mouse Chd2 protein sequence was performed to
establish the number of SQ-potential phosphorylation sites, locate the SQ sites, and
evaluate the amino acids in the N-1 and N-3 positions. Calculations were then made to
determine which sites were most viable to ATM phosphorylation.
Cloning of murine Chd2 gene segments
Previous work in the lab created a nearly full length, 1395 amino acid Chd2 clone
containing an HA (hemaglutanin) tag. To create this clone, a series three of
commercially available (Open Biosystems) cDNA clones that were homologous to the
Chd2 protein were used. It was found through a blast comparison that mouse Chd2 and
human Chd2 had 94% homology, so mouse Chd2 was used. The first clone, M2021 in a
PT7T3D-Pacl vector, contained the base pairs for the first 140 amino acids. Clone 2,
named M5007, was in a pSport6 mammalian vector and contained 1143.3 amino acids
after the M2021 clone. There was an 80 base pair overlap between the end of M2021 and
the start of M5007. Restriction sites were added in order to cleave the clones at
appropriate sequences. M2021 clone was introduced into the pSport6 vector through
cloning and digestion with enzymes Xho 1 and Not 1. The M5007 clone was cut with SaIl
and Not1 and the two cut clones, M2021 and M5007, were ligated together to form
temporarily named clone PChd3KJ.
C-terminal HA-tagging of 1395 aa of Chd2
To create the HA-tagged portion of the final clone, the last of the three
commercial cDNA clones, M6213, was used. Forward primer 5007EF began by
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overlapping part of the M5007 region and the CTHAX reverse primer coded for an HA
tag and Xba1 restriction site. The resulting product contained a portion of Chd2, an HA
tag, and an Xba1 site. This, and the previously created PChd3KJ were cut with Xba1 and
ligated together within the pSport6 vector. The final clone PChdKHA(CT) was finished.
It consists of part M2021, part M5007, and part M6213, and codes for two

chromo domains, the helicaselATPase domain, and several bipartite nuclear localization
signals within the Chd2 protein.
Immunofl uorescence:
Two 2-well chamber slides were seeded with 25,000 U20S cells per chamber.
Immunofluorescence was done after transfection with the PChdKHA(CT) clone to
confirm localization of the clone to the nucleus. Briefly, the chamber slides were fixed in
acetone: methanol, rinsed with Tris buffered saline, then incubated with antibody dilution
buffer (3%BSA, 10% goat serum, 0.05% Triton X-100 in PBS pH 7.4) ADB, for an hour.
Primary antibody, mouse anti-HA (1: 1000 in ADB) was applied for 4 hours in a humidity
chamber at room temperature. After 3 x 2ml/10min washes of working ADB, secondary
antibody was added. Fluoroisothiocyanate (FITC) conjugated goat a-mouse (1 :250 in
ADB) was incubated in the humidity chamber for 1 hour at room temperature. The
chamber walls were removed and each slide was washed with PBS-Photoflo (0.2%),
PBS-Triton (0.05%), and PBS-Photoflo (0.2%) for 10 minutes each. The DNA was
stained with DAPI (4',6-diamidino-2-phenylindole), and after completely removing the
final stain, each slide was sealed with a cover-slip. Each slide was viewed using
immunofluorescence microscopy.
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A western blot was also performed to confirm the success of the transfection.
Celllysates were prepared with cold lysis buffer containing protease and phosphotase
inhibitors, then sonicated. The lysates were loaded into a 5.5% SDS-PAGE mini-gel.
Post-electrophoresis, the gel was transferred onto a 0.45flm PVDF membrane overnight.
The membrane was blocked in 5% blotto for several hours, then rinsed with three
appropriate volumes of TBS/Tween at 5 minutes each, at room temperature. The primary
antibody, mouse a-HA (1 :1000 in 2% blotto), was added to the membrane for 2 hours at
room temperature. The membrane was then washed with TBS/Tween for 10 minutes,
followed by another 10 minutes in 2% blotto, and a final 10 minute wash in TBS/Tween.
The secondary antibody, a-mouse HRP (1 :2000 in 2% blotto), was applied for 1 hour at
room temperature. The membrane was then rinsed three times in TBS/Tween for 20
minutes each. 2 ml of SuperSignal West Pico Chemiluminescent Substrate (Pierce) was
added to the membrane for 3 minutes. The film was developed after a 5 minute exposure.
Expression and phosphorylation of Chd2:
293T cells were plated in antibiotic free media and cultured overnight.
Transfection was performed using the Lipofectamine kit according to amufacturer's
suggestions (Invitrogen). Fresh media was added 4 hours and cells were treated with
different DNA damaging agents after 48 hrs of post-transfection and incubated for
specific times as shown in table 1.
1
U ntransfected
arid untreated
control

2
X-ray
50j
30 min

3
X-ray
50j
2 hr

4
0.1% MMS
30 min

5
0.1% MMS
2 hr

6
UV
40gy
30 min

7
UV
40gy
2 hr

Table 1. DNA damage treatment scheme. Table shows the plate and specific treatment of
the cells expressing Ha-tagged Chd2 peptides.
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After treatment, cells were collected, washed in media, and resuspended in cold
lysis buffer (l50mM NaCI + 50mM Tris pH 8) containing protease and phosphotase
inhibitors. The lysates were then subjected to sonication to shear the DNA. After the
shearing step, 250 J.!l of cell lysate was incubated with 1 ~ll DNase and 2.5 J.!IIM MgS04
and rocked at room temperature for 30 minutes. 250 J.!l NET gel buffer with 2mM EDTA
and 20 J.!l of HA beads was added. The complex was rocked at 4°C overnight. The
following day, after a short centrifugation, the bead-protein complex was washed 3 times
with 500 J.!l cold NET gel buffer containing protease inhibitor/phosphotase inhibitor each
time. To the pellet, IX SDS loading buffer was added and samples were boiled at 95°C
for 3 minutes, and loaded onto a 5.5% SDS-PAGE mini-gel. After electrophoresis, the
gel was transferred onto a 0.45 J.!m PVDF membrane and blocked for several hours, then
rinsed with three 5 minute washes ofTBS/Tween at room temperature.
Western blots were perfonned with antibodies specific for a-ATM/ATR
phosphorylated SQ/ST antibody (1:1000 in 2% blotto overnight at 4°C) and secondary
antibodies a-rabbit HRP (1 :2000 in 2% blotto, 1 hr at room temperature). The membrane
was rinsed three times in TBS/Tween washes of 20 minutes each between incubations.
SuperSignal West Pico Chemiluminescent Substrate was used to develop the membrane.
The film was left for two exposures, at 30 minutes and 1 hour. After stripping the
membrane with washing buffer (lXTBS + 0.5M NaCh + 0.2M SDS), the membrane was
reblocked with 5% blotto. The subsequent western blot was perfonned using primary
antibody a-HA (1:1000 in 2% blotto) incubated for 1.5 hours and secondary antibody a
mouse HRP (l :2000 in 2% blotto) incubated for 1 hour and developed as described
above.
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Results
Computational analysis of Chd2 sequence for SQ motifs
Computational analysis of the mouse Chd2 amino acid sequence showed a total of
ten sq motifs. 5/1 0 SQ motifs had a hydrophobic amino acid at either the N-1 or N-3
position; 1110 SQ motifs had a hydrophobic amino acid at the N-3; 3110 SQ motifs had a
hydrophobic amino acid at the N-1 position; finally, only 1110 SQ motifs had the
necessary hydrophobic amino acids at the N-1 and N-3 positions. (See Fig. 3).
SQ Sequence Motifs:
1. nkdksqe
2. sdsgsqs
3. essesqs
4. agsksqp
5.

6.
7.
8. kskrsqg
9. dslisqs

10.r.sppsqk
Figure 3. Comparison of ten prospective ATM phosphorylation site S/Q motifs.
Each sequence includes the SQ motif, four preceding amino acids, and one following amino acid.
Green highlights denote the N-I and N-3 positions; red highlights denote hydrophobic amino
acids in the N-1 and/or N-3 position.

Expression and nuclear localization of HA-Chd2 peptide
To determine the expression levels and the sub cellular localization of the HAtagged Chd2 peptide, we performed western-blot and immuno-fluorescence assays. The
western blots confirmed the optimal expression of the HA-tagged 1395 amino acid Chd2
clone as shown in figure 4a. Immunofluorescence analysis demonstrated the localization
of the PChdKHA(CT) clone within the nucleus of the transfected U20S cells. As shown
in figure 4b, expression analysis ofHA-Chd2 using anti-HA antibodies indicated that the
HA-Chd2 peptide was confined only to the nucleus. The overlapping of nuclear staining
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with DAPI and HA-Chd2 signal with FITC conjugated secondary amino acids signified
the localization of the expressed peptide to the nucleus (Figure 4b). This is consistent
with the fact that the HA-tagged Chd2 peptide contains four bipartite nuclear signals
within its sequence.

a.

b.

Untransfected

Transfected
~b>~ J;;'--~_~1!;:~"

"!;

'"

-,,"I,.

_

Figure 4. Expression and subcellular localization ofHA-tagged Chd2. The representative
western blot using a-HA antibody to demonstrate expression ofHA-tagged Chd2 into cells is
shown in panel a. The fluorescently stained images on the left (panel b) show the nuclear staining
by the DNA binding dye, DAPI. The right panel shows expression ofHA-tagged Chd2 that is
visualized by FITC staining.
ATM phosphorylation of HA-Chd2
To determine, if the exogenously expressed HA-Chd2 peptide was
phosphorylated after DNA damage, we performed immunoprecipitation analysis
followed by immunoblot analysis with antibodies specific for phosphorylated SQ/ST
motifs. The western blots with a-ATMIATR phosphorylated SQ/ST antibodies were
inconclusive. The a-HA film showed expected bands for our HA-tagged 1395 amino
acid Chd2 clone at ~ 160 Kd (figure 5). Importantly we did not detect any
phosphorylated bands around 160 Kd indicating that the HA-tagged Chd2 peptide is not
phosphorylated under the conditions that were analyzed. The a-ATMIATR
phosphorylated SQ/ST blot, however, produced a non-specific band at a lower molecular
weight

(~ 130

kD) than the expected molecular weight ofHA-Chd2 peptide in all the
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transfected and un-transfected samples. The presence of the novel band in the un
transfected samples also suggested that the novel band may be a non-specific cellular
protein bound by the anti-HA sepharose beads.

Con.

MMS

UTr. Tr. O.5h 2h

-160k

-130k

UV

X-ray

O.5h 2h

O.5h 2h

'~I""I· .... -Chd2

(anti-HA)

Non-specific
Peptide (anti-pSQ/ST)

Figure 5. Analysis of SQ/ST phosphorylation patterns of HA-Chd2. Comparison of a
HA and a-ATMIATR phosphorylated SQ/ST western blots is shown above. UTr., untransfected
control; Tr., transfected untreated control.

Discussion
The Chd2 protein has 2 chromodomains and a helicaselA TPase domain,
suggesting it has a role in chromatin remodeling, chromosomal stability, and DNA repair.
Our lab previously created a knockout mouse model for Chd2 using gene trap
technology. We found that mice heterozygous for Chd2 had a propensity to develop
lymphomas, and nullizygous mutants suffered from neonatal lethality. Based on the
previous observations, we hypothesized that Chd2 plays an important role in genomic
stability maintenance.
In an effort to determine the biochemical functions of Chd2 that relate to genome
stability maintenance we sought to determine if Chd2 was a substrate of the DNA
damage inducible kinase, ATM. Sequence analysis of the mouse Chd2 protein also
suggested ten potential SQ motifs for ATM phosphorylation. To investigate whether
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Chd2 is a potential substrate of ATM, a recombinant Chd2 peptide (1395 amino acid
Chd2 tagged with HA) was created and expressed in 293T and U20S cells. HA-Chd2
transfected human cancer cells were exposed to three DNA damage-causing agents.
Expression and localization of the recombinant peptide into the nucleus was confirmed
by western blot and immunofluorescence, respectively.
The ATM phosphorylation experiment yielded unexpected results in that the
bands from the anti-HA blot and the anti-ATM/ATR phosphorylated SQ/ST did not
match. The HA blot expressed expected bands for HA-tagged Chd2 between 160 - 170
kD. The a-ATMlATR phosphorylated SQ/ST blot revealed a lower molecular weight
band. Even though the band does not represent Chd2, its mere presence indicates that
something else within the cell is being phosphorylated by ATM or ATR, as the antibody
is extremely specific to ATMIATR-phosphorylated SQ/ST motifs. It is unclear as to
what this unknown ATM substrate could be because ATM has numerous substrates,
some of which are still unidentified. The a-ATM/ATR phosphorylated SQ/ST blot also
showed evidence of phosphorylation of the non-specific protein in the untransfected
control, suggesting an SQ or ST motif may have acted upon by constitutive ATM
phosphorylation activity without DNA damage. The 293T cell line was originally chosen
for its fast growth, high transfection efficiency, and ease of manipulation; however, after
further research, it was found that 293T cells may not be the best cells for use in ATM
phosphorylation experiments. The 293T cells are human embryonic kidney cells
transformed by a rare adenovirus integration event that alters E 1A and

B genes, among

several others [18]. Further literature searches found that 293 cells are highly susceptible
to a variety of virus transformants including herpes simplex virus, parainfluenza virus,
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and respiratory syncytial virus [19]. Furthermore, simian virus 40 (SV 40) affects A TM
functioning and SV 40 expression can activate ATM and subsequently affect downstream
A TM substrates and pathways [20]. These findings and our inconclusive results suggest
that 293T is an unsuitable cell line for DNA damage response related studies. This is due
to the fact that expression of SV40 in 293 T cells makes it difficult to distinguish the
differences between the effects of constitutive ATM activation by SV40 and the
experimental DNA-damaging treatments.

Future Work
There are several possible avenues for continuing with this work. As discussed,
the ATM phosphorylation experiment with 293T cells was not successful. Currently, the
ATM phosphorylation of Chd2 experiment is being repeated using U20S cells, which are
better suited for the experiment. U20S cells are derived from bone tissue of an
osteosarcoma patient [21]. They resemble epithelial cells and are free of adenoviruses,
RSV, and most importantly, SV40, making them useful for DNA damage studies
involving tumor suppressor genes [21]. Concurrently, our lab has developed a 1395
amino acid Chd2 clone with Tandem affinity purification (TAP) tags containing histidine
and strep tags. We plan to repeat the A TM experiment with TAP-tagged Chd2 in U20S
cells. If the ATM phosphorylation experiments are successful, an in vitro kinase assay
would be performed to determine whether Chd2 is phosphorylated by ATMIA TR. As a
substrate, purified Chd2 will be used in conjunction with kinase obtained from U20S
cells and AT deficient cell lines. The results of this experiment would help determine if

•
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Chd2 is indeed phosphorylated by ATM after DNA damage and provide mechanistic
insights on the role of Chd2 in DNA damage response pathways.

•
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